Join the LinkedIn group.

Past Webinar:

• To Consult or Not To Consult? The Role of the Consultant in Drug Discovery
• Pre-Emptive Pharmacogenomic Testing Reduces the Risk of Adverse Drug Reactions by 30%: The Time for Implementation is Now
• ASCPT Early Career (EC) Community Interview Series Featuring: Daniele Ouellet, PhD, and Karen Rowland Yeo, PhD (open access)
• Recent Perspectives and Advances on the Development of Cell Therapies for Cancer
• The Good, the Bad, and the Ugly of Scientific Talks and Poster Sessions
• ASCPT Early Career (EC) Community Interview Series Featuring: Antoinette Ajavon-Hartmann, PhD (open access)
• Introduction of Deep Learning in Drug Discovery and Development, Part 3 – Computer Vision with Convolutional Neural Networks (CNNs)
• Introduction of Deep Learning in Drug Discovery and Development, Part 2: Artificial Neural Networks (ANNs)
• Introduction of Deep Learning in Drug Discovery and Development Part 1
• Effective Visual Communication for Quantitative Scientists, Part 2
• Effective Visual Communication for Quantitative Scientists, Part 1
• Early Career Interview with Certara's Ellen Leinfuss
• Pharmacogenomics Studies in Caribbean Hispanics Bridging the Gap to Reduce Healthcare Disparities
• Mental Health & Addiction (MHA) and Early Career (EC) Communities Interview Series Part 2
• Translational and Clinical Pharmacology Considerations in the Development of Immune Oncology Drugs (Encore Presentation)
• Mental Health & Addiction (MHA) and Early Career (EC) Communities Interview Series Part 1
• Who Is an Editor-in-Training?
• Staying Engaged in Your Career Without Burning Out: A Call for Action to Build Resilience
• ASCPT Interview Series Featuring Don Heald, PhD, and Kellie Reynolds, PharmD
• Translational and Clinical Pharmacology Considerations in the Development of Immune Oncology Drugs
• Early Career ‘Pearls’ and ‘Pitfalls’ – What I Wish I Had Known in My First Five Years!
• Coffee Break with the ASCPT’s Editors- in-Training